Neoadjuvant Use of Ipilimumab in Locally Advanced Melanoma

被引:7
|
作者
Howie, Lynn J. [1 ,2 ]
Tyler, Douglas S. [2 ]
Salama, April K. S. [1 ,3 ]
机构
[1] Duke Univ, Div Med Oncol, Trinity, NC USA
[2] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA
[3] Duke Canc Inst, Durham, NC USA
关键词
melanoma; ipilimumab; immunotherapy; neoadjuvant; RESECTION; PATIENT; TRIAL;
D O I
10.1002/jso.24079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent advances in immune modulating therapies show great promise for patients with advanced melanoma, however optimal strategies for achieving long-term disease control in locally advanced melanoma are unclear. We present two cases of neoadjuvant ipilimumab, one case in combination with isolated limb infusion (ILI) followed by surgical resection and one followed by surgery alone. Both patients have had durable responses. These cases highlight the ongoing need for prospective trials in the neoadjuvant setting. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:841 / 843
页数:3
相关论文
共 50 条
  • [1] Neoadjuvant Ipilimumab/Nivolumab combination in locally advanced or oligometastatic melanoma
    Ferrucci, Pier Francesco
    Lanfrancone, Luisa
    Mazzarella, Luca
    Nezi, Luigi
    Duso, Bruno Achutti
    Manzo, Teresa
    Lotti, Fiorenza
    Gandini, Sara
    Orsolini, Gianmarco
    Pennacchioli, Elisabetta
    Gnagnarella, Patrizia
    Fierro, Maria Teresa
    Senetta, Rebecca
    Riviello, Concetta
    Caliendo, Virginia
    Quaglino, Pietro
    Mazzarol, Giovanni
    Bonizzi, Giuseppina
    Cocorocchio, Emilia
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (SUPPL 1)
  • [2] Neoadjuvant ipilimumab in locally/regionally advanced melanoma: Clinical outcome and biomarker analysis
    Tarhini, Ahmad A.
    Edington, Howard
    Butterfield, Lisa H.
    Shuai, Yongli
    Lin, Yan
    Rao, Uma N.
    Kirkwood, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
  • [3] Neoadjuvant ipilimumab in locally/regionally advanced melanoma: Clinical outcome and immune monitoring
    Tarhini, Ahmad A.
    Edington, Howard
    Butterfield, Lisa H.
    Tawbi, Hussein
    Moschos, Stergios J.
    Shuai, Yongli
    Lin, Yan
    Horak, Mary
    Sarkisian, Saro
    Shipe-Spotloe, Janice
    Milburn, Christy
    Sander, Cindy
    Johnson, Jonas Talmadge
    Kirkwood, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Neoadjuvant Immunotherapy for Locally Advanced Melanoma
    Meredith S. Pelster
    Rodabe N. Amaria
    [J]. Current Treatment Options in Oncology, 2020, 21
  • [5] Neoadjuvant Immunotherapy for Locally Advanced Melanoma
    Pelster, Meredith S.
    Amaria, Rodabe N.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
  • [6] Preliminary results of a Neoadjuvant combo-immunotherapy with ipilimumab and nivolumab in locally advanced or limited metastatic melanoma
    Ferrucci, Pier Francesco
    Pala, Laura
    Conforti, Fabio
    Nezi, Luigi
    Manzo, Teresa
    Cocorocchio, Emilia
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [7] Neoadjuvant therapy of locally/regionally advanced melanoma
    Khunger, Arjun
    Buchwald, Zachary S.
    Lowe, Michael
    Khan, Mohammad K.
    Delman, Keith A.
    Tarhini, Ahmad A.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [8] Ipilimumab: A Guide to Its Use in Advanced Melanoma
    Lyseng-Williamson, Katherine A.
    Sanford, Mark
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (05) : 349 - 354
  • [9] Ipilimumab: A Guide to Its Use in Advanced Melanoma
    Katherine A. Lyseng-Williamson
    Mark Sanford
    [J]. American Journal of Clinical Dermatology, 2012, 13 : 349 - 354
  • [10] Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma
    Meredith A. McKean
    Rodabe N. Amaria
    [J]. American Journal of Clinical Dermatology, 2018, 19 : 639 - 646